‘All we are asking is for the judiciary to follow government guidance’- FDA writes to the Lord Chief Justice

The FDA has written to the Lord Chief Justice, Lord Burnett, to raise serious concerns about the approach taken by some members of the judiciary to applications from prosecutors to appear in court remotely.
The union has received deeply concerning reports from members working in the CPS about the attitude of some judges, with reported conduct including asking for inappropriate personal details from advocates who are shielding, and suggesting prosecutors were ‘working to rule’ for applying to appear remotely.
In the letter, the FDA argued that there should not be “any need for prosecutors to be forced to justify why they wish to appear via live link. Their wish to follow both their employer’s guidance and the official government guidelines should be sufficient to meet the ‘interests of justice’ test.”
“The use of Cloud Video Platform has worked well during the crisis and we believe that this should be the default means by which advocates appears in court for the foreseeable future.”
The letter made clear that the FDA recognises that attendance at court is a judicial function, and there will be a limited number cases where physical attendance is necessary, but these should be the exception, not the rule.
“Comments from some judges insinuating that prosecutors who wish to appear remotely are shirking or being difficult are extremely troubling,” said Steven Littlewood, FDA National Officer for the Crown Prosecution Service.
“Our members have continued to work hard throughout this crisis and there is absolutely no reason to doubt their dedication now. All we are asking is for the judiciary to follow the government and civil service guidance.”
The Judicial Office confirmed when approached for comment by the Law Society Gazette that the letter had been received and the Lord Chief Justice would respond.
Related News
-
FDA reps in Dstl awarded the Group Impact Award 2025
Katherine Hutchinson speaks to the winners of the Group Impact Award 2025: FDA reps Gareth Conway, Karen Craddock, Matt Gibb and Simon Botting at the Defence Science and Technology Laboratory (Dstl).
-
Structure over speed: Dame Wendy Hall on artificial intelligence in the civil service
Professor Dame Wendy Hall shares how artificial intelligence can assist the civil service, but shouldn’t be treated as a quick fix.
-
Inside UK PLC: Penman discusses recent trip to Warsaw with FCDO
In May, FDA General Secretary Dave Penman visited Warsaw and its embassy to help highlight the significant work of our Foreign, Commonwealth and Development staff, based in countries across the globe.